StudyAgeing research reviewsNov 2026
Montenegro CF, Murach KA, Chambers TL.
Age-associated loss of muscle mass and function, termed sarcopenia, increases morbidity and mortality risks concomitant with decreased physical activity. Chronic exercise training is the most effective countermeasure against sarcopenia, but physical limitation...
StudyJournal of Alzheimer's disease : JADOct 2026
Kamihara T, Kato R, Morisaki A, Kaneko S, Omura T, Shimizu A.
BackgroundAlzheimer's disease (AD) currently lacks fundamental curative treatments. While epidemiological evidence increasingly links sodium-glucose cotransporter 2 (SGLT2) inhibitors to reduced AD risk, the underlying molecular mechanisms remain poorly unders...
StudyEndocrineOct 2026
Jain V, McCoy RG.
Purpose Sodium-glucose cotransporter-2 inhibitors (SGLT2i) carry Class I, Level A recommendations for type 2 diabetes (T2D), heart failure (HF), and chronic kidney disease (CKD) but remain underused outside T2D, with formulary restrictions commonly cited as a ...
StudyGeroScienceOct 2026
Smith C, Garza K, Azari H, Vellers H, Abdelrahman M, Dhanasekara CS, Salmon AB, Liang H, Fernandez E, Musi N, Massett MP, Albracht-Schulte K.
Aerobic exercise attenuates age-related physiological decline, potentially through favorable modulation of gut microbiota diversity. The purpose of this study was to characterize aerobic exercise training (ET)-induced alterations in the gut microbiome of aging...
StudyJournal of exercise rehabilitationOct 2026
Park JW, Yoo DH, Jo SG, Jee YS.
This pilot randomized controlled trial (RCT) aimed to determine whether an 8-week progressive step exercise program improves sarcopenic outcomes compared with treadmill exercise and a nonexercise control condition in women with sarcopenia. The primary outcomes...
StudyFrontiers in cardiovascular medicineOct 2026
Seri A, Yue B, Khawaja M, Tang WHW, Birnbaum Y, Lavie CJ, Virani SS, Strauss M, Krittanawong C.
Cardiovascular health is a key factor in human longevity, affecting not just lifespan but also the quality of aging. We synthesize evidence across four risk factor domains: genetic and epigenetic factors (APOE, FOXO3, telomere biology, epigenetic clocks); meta...